-- Preview Email Newsletter
State Tipoffs Involving Delaware Newsletter for 2025-05-11 ( 7 items ) |
Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture (10)
WILMINGTON, Delaware, May 7 -- Chemours, a provider of titanium technologies, fluoroproducts and chemical solutions, issued the following news release:
* * *
Chemours and Navin Fluorine Announce Agreement to Manufacture New Liquid Cooling Product as a Part of Chemours Expanded Liquid Cooling Venture
Partnership to establish initial capacity & enable adoption of Opteon two-phase immersion cooling fluid to address data center cooling needs created by AI and next-generation chips
Wilmington, De more PR
Chemours Company Reports First Quarter 2025 Results (10)
WILMINGTON, Delaware, May 7 -- Chemours, a provider of titanium technologies, fluoroproducts and chemical solutions, issued the following news release:
* * *
Chemours Company Reports First Quarter 2025 Results
Wilmington, Del., May 6, 2025 - The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced i more PR
DuPont Reports First Quarter 2025 Results (10)
WILMINGTON, Delaware, May 2 -- DuPont issued the following news release:
* * *
DuPont Reports First Quarter 2025 Results
* Net Sales of $3.1 billion increased 5%; organic sales increased 6% versus year-ago period
* GAAP Loss from continuing operations of $(548) million, includes $768 million non-cash goodwill impairment charge related to first quarter segment realignment; operating EBITDA of $788 million
* GAAP EPS from continuing operations of $(1.33); adjusted EPS of $1.03
* Cash prov more PR
ENHERTU Followed by THP Before Surgery Showed Statistically Significant and Clinically Meaningful Improvement in Pathologic Complete Response in Patients With High-Risk HER2-Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase III Trial (10)
WILMINGTON, Delaware, May 8 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
ENHERTU (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial
AstraZeneca and Daiichi Sankyo's ENHERTU followed by THP
showed an improved safety profile vs. standard more PR
IMFINZI (durvalumab) Regimen Demonstrated Statistically Significant and Clinically Meaningful Improvement in Disease-Free Survival for High-Risk Non-Muscle-Invasive Bladder Cancer in POTOMAC Phase III Trial (10)
WILMINGTON, Delaware, May 10 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
IMFINZI (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial
Patients lived significantly longer without high-risk disease recurrence or progression after one year of IMFINZI treatment plus Bacillus Calmette-Guerin (BCG) induction and m more PR
Pa. Auditor General DeFoor Announces Release of Compliance Audits for County Offices, District Courts (10)
HARRISBURG, Pennsylvania, May 9 -- Pennsylvania Auditor General Timothy DeFoor issued the following news release on May 8, 2025:
* * *
Auditor General DeFoor Announces Release of Compliance Audits for County Offices, District Courts
HARRISBURG - Auditor General Timothy L. DeFoor today announced the release of compliance audits for district courts and county government offices in Allegheny, Blair, Cambria, Carbon, Centre, Clearfield, Dauphin, Delaware, Greene, Lehigh, Luzerne, Lycoming, Monroe more PR
UB School of Management Celebrates Career Partners for Impact on Student Success (10)
BUFFALO, New York, May 10 -- The University at Buffalo (State University of New York) issued the following news release:
* * *
UB School of Management celebrates career partners for impact on student success
By Kevin Manne
BUFFALO, N.Y. -- The Career Resource Center -- an exclusive resource for nearly 4,000 students in the University at Buffalo School of Management -- hosted a celebration at The Mansion on Delaware Ave. May 7 to honor several recruiting and internship partners for their cons more PR
|